Cytocompatibility of MG-63 osteosarcoma cells on chitosan/hydroxyapatite/lignin hybrid composite scaffold in vitro

Biomed Mater. 2022 Nov 10;18(1). doi: 10.1088/1748-605X/ac9f92.

Abstract

This study aims at fabricating promising cytocompatible hybrid biocomposite scaffolds from chitosan (CS), hydroxyapatite (HAP) and lignin (L) for bone tissue engineering by using freeze-drying technique. Different ratios of HAP to L (50:0, 37.5:12.5, 25:25 and 12.5:37.5) were taken to determine the optimum ratio for obtaining a composite with superior properties. The mechanical and biological properties of the resulting composites were investigated. The mechanical results showed that the prepared composite with a ratio of 25:25 of HAP/L exhibited a remarkable enhancement in the mechanical properties compared to the others. Additionally, it was found from thein vitroresults that the addition of L enhanced the water uptake value of the resulting scaffolds indicating their increased hydrophilicity. As a result, a significant increase in the attachment and proliferation of MG-63 cell line (osteoblast like cells) was observed in composite scaffolds with L over the scaffold without L (CS/HAP). From these results, it could be suggested that the prepared composite scaffold with 25:25 of HAP/L is very promising biomaterials in bone tissue-engineering as it exhibited a better mechanical and biological properties than the other prepared composites.

Keywords: MG-63 cell line; biocomposite; chitosan; lignin; scaffolds.

MeSH terms

  • Biocompatible Materials
  • Chitosan*
  • Durapatite
  • Humans
  • Lignin
  • Osteosarcoma*
  • Tissue Engineering / methods
  • Tissue Scaffolds

Substances

  • Durapatite
  • Chitosan
  • Lignin
  • Biocompatible Materials